Xspire Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for XSPIRE PHARMA, and when can generic versions of XSPIRE PHARMA drugs launch?
XSPIRE PHARMA has six approved drugs.
There are two US patents protecting XSPIRE PHARMA drugs.
There are one hundred and fifty-five patent family members on XSPIRE PHARMA drugs in thirty-seven countries and twenty-two supplementary protection certificates in sixteen countries.
Summary for Xspire Pharma
| International Patents: | 155 |
| US Patents: | 2 |
| Tradenames: | 6 |
| Ingredients: | 5 |
| NDAs: | 6 |
Drugs and US Patents for Xspire Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xspire Pharma | DEXAMETHASONE | dexamethasone | TABLET;ORAL | 088237-001 | Apr 28, 1983 | BP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Xspire Pharma | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-004 | Jul 21, 2009 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Xspire Pharma | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | RX | Yes | Yes | 7,304,078 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Xspire Pharma | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | RX | Yes | Yes | 7,713,999 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Xspire Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Xspire Pharma | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | 7,235,567 | ⤷ Try a Trial |
| Xspire Pharma | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-003 | Approved Prior to Jan 1, 1982 | 3,600,437 | ⤷ Try a Trial |
| Xspire Pharma | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-002 | Approved Prior to Jan 1, 1982 | 3,600,437 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Xspire Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Slovenia | 1294714 | ⤷ Try a Trial |
| Ecuador | SP045368 | ⤷ Try a Trial |
| European Patent Office | 1701953 | ⤷ Try a Trial |
| Cyprus | 1111363 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Xspire Pharma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1495018 | PA2015027,C1495018 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: VORAPAKSARAS; REGISTRATION NO/DATE: EU/1/14/976/001 - EU/1/14/976/006 20150119 |
| 1495018 | 122015000053 | Germany | ⤷ Try a Trial | PRODUCT NAME: VORAPAXAR ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150119 |
| 1495018 | CR 2015 00037 | Denmark | ⤷ Try a Trial | PRODUCT NAME: VORAPAXAR, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING VORAPAXARSULPHATE; REG. NO/DATE: EU/1/14/976/001-06 20150119 |
| 1495018 | PA2015027 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: VORAPAXARUM; REGISTRATION NO/DATE: EU/1/14/976/001 - EU/1/14/976/006 20150119 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
